Clinical Trials for Insightec

Explore 32 clinical trials worldwide

Showing 1-32 of 32 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Insightec

Clinical Trials (32)

NCT06974916
EMBRACE Tremor BiFUS
NARecruiting
100 participants
Started: Apr 22, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor4 locations
NCT06584383
A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease
NARecruiting
72 participants
Started: Aug 1, 2024 · Completed: Sep 30, 2029
1 condition1 sponsor4 locations
NCT06367608
MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)
NARecruiting
10 participants
Started: Jun 10, 2024 · Completed: Jun 30, 2028
1 condition3 sponsors1 location
NCT06292494
Focused Ultrasound for Drug-resistant Epilepsy
NARecruiting
20 participants
Started: Jan 1, 2024 · Completed: Dec 31, 2027
5 conditions2 sponsors1 location
NCT05539196
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
N/ARecruiting
60 participants
Started: Jan 23, 2023 · Completed: Jul 31, 2029
3 conditions1 sponsor5 locations
NCT05615623
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG
PHASE1/PHASE2Recruiting
10 participants
Started: Jan 4, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05630209
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
PHASE1/PHASE2Recruiting
10 participants
Started: Jan 4, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT05565443
MR-guided Focused Ultrasound Plus GCase
NARecruiting
14 participants
Started: Nov 30, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05317858
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
PHASE3Recruiting
30 participants
Started: Aug 12, 2022 · Completed: Dec 1, 2027
2 conditions1 sponsor7 locations
NCT05469009
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
EARLY_PHASE1Active, not recruiting
15 participants
Started: Jul 14, 2022 · Completed: Jul 31, 2029
2 conditions2 sponsors1 location
NCT04991831
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
N/ARecruiting
50 participants
Started: Apr 28, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor8 locations
NCT04579692
MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia
NAActive, not recruiting
10 participants
Started: Aug 16, 2021 · Completed: Dec 15, 2025
1 condition3 sponsors1 location
NCT04728295
Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)
NAActive, not recruiting
50 participants
Started: May 14, 2021 · Completed: Dec 1, 2028
1 condition1 sponsor9 locations
NCT04559685
Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma
EARLY_PHASE1Recruiting
30 participants
Started: Mar 15, 2021 · Completed: Mar 31, 2028
1 condition5 sponsors1 location
NCT04417088
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Nov 6, 2020 · Completed: Jul 31, 2024
1 condition1 sponsor4 locations
NCT04440358
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PHASE1/PHASE2Active, not recruiting
13 participants
Started: Oct 13, 2020 · Completed: Jul 31, 2024
1 condition1 sponsor3 locations
NCT04112381
Bilateral Treatment of Medication Refractory Essential Tremor
NAActive, not recruiting
51 participants
Started: Jun 30, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor7 locations
NCT04123535
Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma
NARecruiting
20 participants
Started: Jan 23, 2020 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT03998657
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions
NAActive, not recruiting
14 participants
Started: Dec 19, 2019 · Completed: Dec 30, 2026
1 condition1 sponsor5 locations
NCT04197921
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
NARecruiting
29 participants
Started: Nov 27, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor4 locations
NCT03465761
Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
NARecruiting
30 participants
Started: Jan 3, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT03671889
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
NARecruiting
150 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT03319485
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease
NAActive, not recruiting
92 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2025
1 condition1 sponsor20 locations
NCT03028246
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
NARecruiting
20 participants
Started: Feb 28, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT03100474
Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:
N/AActive, not recruiting
500 participants
Started: Dec 31, 2016 · Completed: Jun 30, 2026
4 conditions1 sponsor9 locations
NCT05386615
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
N/ARecruiting
200 participants
Started: Feb 16, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor6 locations
NCT02252380
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
NAActive, not recruiting
10 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
9 conditions1 sponsor2 locations
NCT02343991
Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound
NAActive, not recruiting
10 participants
Started: Oct 31, 2014 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT02246374
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
NAActive, not recruiting
7 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT02347254
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
NAActive, not recruiting
6 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT00147056
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NAActive, not recruiting
10 participants
Started: Aug 31, 2012 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT01473485
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
NAActive, not recruiting
10 participants
Started: Apr 30, 2011 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location